As co-leader of our Intellectual Property practice group, Daisy manages litigation teams while leading clients to victories in court and before the U.S. Patent & Trademark Office’s Patent Trial and Appeal Board (PTAB).
Daisy manages cases from beginning to end—from initial investigations to strategy development to eventual settlement efforts, trial or appeals, including appeals that have at times reached the U.S. Supreme Court. She’s known for her thorough knowledge of every case and client she works with, and she has a special focus on defending small and medium-sized companies in litigation against major corporations.
In addition to traditional litigation, Daisy has an exceptional track record leading a variety of clients through inter partes review before the PTAB. In cases where the law wasn’t clearly on the client’s side, she has successfully pushed for changes in the law’s interpretation. On a few occasions, Daisy’s novel, innovative strategies before PTAB have led to precedential opinions, shifting the law—and the strategies pursued by other law firms—going forward.
Clients often remark on how much Daisy genuinely cares about their business: she takes client business interests very seriously, even when that means not pursuing litigation. Daisy is aware that, when there’s a successful path out of litigation, it’s often best business practice to take it. Her goal is always to partner with clients to develop the best business strategy to resolve their legal issues.
At the beginning of 2022, Daisy became co-chair of Husch Blackwell’s Intellectual Property practice group. She manages the majority of the firm’s intellectual property litigation matters and the intellectual property docket, working to achieve a balance of experience levels on each case. Daisy has extensive experience managing litigation teams and frequently coordinates attorneys across multiple offices throughout the country.
Prior to attending law school, Daisy worked as a research specialist at WiCell Research Institute, where she participated in groundbreaking research on human embryonic stem cell pluripotency and self-renewal.